Jonathan Alspaugh

Insider Reports History

Location
Austin, TX
Signature
/s/ Jonathan Alspaugh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Alspaugh:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. President and CFO Employee Stock Option (right to buy) 19,787,969 22 Jun 2023 Direct

Insider Reports Filed by Jonathan Alspaugh

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRE Aeglea BioTherapeutics, Inc. 22 Jun 2023 1 $0 4 President and CFO 30 Jun 2023, 16:34
SYRE Aeglea BioTherapeutics, Inc. 23 Feb 2023 1 $0 4 Chief Financial Officer 24 Feb 2023, 17:20
SYRE Aeglea BioTherapeutics, Inc. 23 Aug 2022 1 $0 4 Chief Financial Officer 25 Aug 2022, 19:34
SYRE Aeglea BioTherapeutics, Inc. 11 Mar 2022 1 +$156,000 4 Chief Financial Officer 15 Mar 2022, 18:30
SYRE Aeglea BioTherapeutics, Inc. 17 Feb 2022 1 $0 4 Chief Financial Officer 22 Feb 2022, 15:50
SYRE Aeglea BioTherapeutics, Inc. 09 Dec 2021 1 +$186,000 4 Chief Financial Officer 13 Dec 2021, 19:37
SYRE Aeglea BioTherapeutics, Inc. 16 Aug 2021 3 +$262,660 4 Chief Financial Officer 18 Aug 2021, 17:21
SYRE Aeglea BioTherapeutics, Inc. 06 Jul 2021 1 $0 4 Chief Financial Officer 08 Jul 2021, 17:12
SYRE Aeglea BioTherapeutics, Inc. 06 Jul 2021 0 $0 3 Chief Financial Officer 08 Jul 2021, 17:10